[Pharmwaste] Re: Pharmwaste Digest, Vol 20, Issue 1
Andy Kubalak
andy.kubalak at epa.state.oh.us
Fri Jun 1 13:05:20 EDT 2007
So what does the bill referenced in Message 7 actually say? Does anyone
have a link to the bill?
>>> <pharmwaste-request at lists.dep.state.fl.us> 6/1/2007 12:17 PM >>>
Send Pharmwaste mailing list submissions to
pharmwaste at lists.dep.state.fl.us
To subscribe or unsubscribe via the World Wide Web, visit
http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste
or, via email, send a message with subject or body 'help' to
pharmwaste-request at lists.dep.state.fl.us
You can reach the person managing the list at
pharmwaste-owner at lists.dep.state.fl.us
When replying, please edit your Subject line so it is more specific
than "Re: Contents of Pharmwaste digest..."
Today's Topics:
1. Safety of cosmetics is a gray area (DeBiasi,Deborah)
2. PPCP webcast presentations from May 22, 07 in Sacramento CA
(DeBiasi,Deborah)
3. Re: Role of the Pharmacist in PharmWaste Management
(Catherine Zimmer)
4. Cocaine in the air in Italy: study (gressitt)
5. Call Out for Karen Norris (drmille at blue.weeg.uiowa.edu)
6. RE: Call Out for Karen Norris (gressitt)
7. CA Pharmaceutical Take-back Legislation Passes Senate!
(Jackson, Jennifer)
----------------------------------------------------------------------
Message: 1
Date: Wed, 30 May 2007 10:47:55 -0400
From: "DeBiasi,Deborah" <dldebiasi at deq.virginia.gov>
Subject: [Pharmwaste] Safety of cosmetics is a gray area
To: <pharmwaste at lists.dep.state.fl.us>
Message-ID:
<6C097DA58429B743A67070F98BE73A37026C3D16 at deqex01.deq.local>
Content-Type: text/plain; charset="iso-8859-1"
http://www.nj.com/business/ledger/index.ssf?/base/business-0/1180239903218120.xml&coll=1
Safety of cosmetics is a gray area
Sunday, May 27, 2007
BY ROBERT COHEN
STAR-LEDGER WASHINGTON BUREAU
WASHINGTON -- POI Products, a leading professional nail- care company,
reformulated its nail polishes, treatments and hardeners in the past
year to remove chemi cals that some have warned could pose potential
health threats.
The California company insisted its products were completely safe and
met all Food and Drug Administration requirements, but said it altered
the formulas to comply with new safety standards recently imposed by the
European Union and to eliminate concerns raised by a number of public
interest groups.
"Rather than getting mired in the question of whether the old for mulas
were safe, I'm sure you will agree it's more important to focus on the
future," Eric Schwartz, chief operating officer of OPI, said in a March
letter to a member group of the Campaign for Safe Cosmetics.
The Campaign for Safe Cosmet ics, a coalition of health and
environmental organizations, for several years has been pressuring
personal-care product and cosmetic companies to phase out chemicals they
say have been linked to cancer, birth defects and other health problems.
The organization has targeted hair dyes, shampoos, mascara,
antiperspirants, deodorants, perfumes, creams, nail polish and other
products. While chemicals in any one consumer item alone are unlikely to
cause harm, the coalition argues, repeated exposure to industrial
chemicals from many different sources on a daily basis could have
negative long-term health consequences.
In the case of OPI, the company eliminated dibutyl phthalate, toluene
and formaldehyde, three po tential carcinogens.
The cosmetic campaign has met with some success, fueled in part by the
EU's 2004 ban on use in cosmetics of more than 1,000 of chemicals known
or strongly sus pected of causing cancer, mutation or birth defects.
The effort also has aided a newly enacted California chemical
ingredient disclosure law for cos metics, and a 2007 EU policy re
quiring all companies, including cosmetic firms that produce or use
chemicals, to collect extensive data on possible human health risks of
the substances.
Now many of the industry's big players are fighting back against the
public campaign, refuting claims there are any health or safety
problems.
John Bailey, executive vice president for science at the Cosmetic,
Toiletry and Fragrance Association, said the industry has a long record
of safety, and spends considerable time and money in scientific research
and product formula tion to ensure the public health is protected.
The claims by the health and environmental groups about carcinogens and
dangerous ingredients in cosmetics, he said, represent "scare tactics"
rather than rigorous science. Their information, he said, is
"incomplete," and "they are not telling the full story."
Bailey, a former head of the FDA's office of cosmetics, acknowledged
some manufacturers such as OPI that market in Europe and want to avoid
public relations problems have decided to make changes in their
products.
"Companies are in business and they have to make decisions for
marketing reasons," Bailey said. "They have to be responsive to consumer
perceptions."
So far, the consumer coalition has convinced about 550 compa nies to
sign a compact agreeing to remove all toxic chemicals and replace them
with safer alternatives. Many of the companies are part of the "natural
products" industry, including the Body Shop, Burt's Bees, Avalon Natural
Products and Aubrey Organics.
But the coalition has met resistance from the big names in cos metics
and personal care products, including EstΘe Lauder, Revlon, Chanel,
Clinique, L'Oreal, Unilever and Procter & Gamble.
"By signing the compact, cos metic companies are giving the activist
groups -- who often do not rely on sound, peer-reviewed science in their
reports -- the authority to define 'safe,'" said an EstΘe Lauder
statement. "Since our company's standards are often higher than most
regulatory boards, we would never relinquish the responsibility of
determining the safety of our ingredients."
EstΘe Lauder, however, recently removed dibutyl phthalate from its nail
polishes to meet EU marketing requirements, while Revlon and other
companies have taken similar steps with some of their product lines.
Under U.S. law, the FDA neither tests, reviews nor approves cosmetics
and personal-care products before they go on the market, and only bans
certain color addi tives and a handful of substances from use.
Under the law, companies are required to list ingredients on product
labels or package inserts and prepare the products under sanitary
conditions. They are prohibited from making false or misleading claims.
"Cosmetic firms are responsible for substantiating the safety of their
products and ingredients be fore marketing," the FDA says in its Web
site.
But the agency has never de fined what constitutes a safe product. The
industry says the standard for a safe product is one that does not
irritate the skin when used as directed.
"Under U.S. federal law, compa nies can put virtually anything they
wish into personal-care products, and many of them do," said Jane
Houlihan, vice president of research for the Environmental Working
Group, one of the members of the Campaign for Safe Cos metics.
While the industry says the number of adverse reactions from cosmetics
is small and confined mostly to skin irritations, Houlihan said, "There
is no requirement that cosmetic injuries be reported and no tracking
system in place."
"Consumers also have no way to know how exposure over a lifetime might
be affecting their health," she added.
Houlihan's organization and others in the coalition, including the
Breast Cancer Fund, Commonweal, Friends of the Earth and the National
Environmental Trust, say they will press Congress to strengthen the FDA
law to set firm standards for testing and safety, ar guing the time is
long overdue and the list of suspect ingredients is quite extensive.
The coalition points to mercury, found in some eye drops, ointment and
deodorants; formaldehyde and toluene, found in nail products; petroleum
distillates, found in some mascara, perfume, foundation, lipstick and
lip balm; ethylacrylate, found in some mascara; coal tar, found in
dandruff shampoos and hair dyes; dibutyl phthalate, found in some nail
polish, perfume and hair spray; and lead acetate, found in some hair
dyes and cleansers.
One company on the Environmental Working Group's "Skin Deep" Web site
database that lists potentially troublesome products is Combe of White
Plains, N.Y., the maker of Grecian Formula hair dyes, which contain lead
acetate.
"We know enough about lead that it should not be in personal- care
products," Houlihan said. "We have taken lead out of house paint and
gasoline. Why are we still using it in men's hair dye?"
Combe spokeswoman Joy Robinson said the company reformulated some
Grecian hair dye products in Canada, where lead acetate was recently
banned, but continues to use the ingredient in the United States, where
the FDA has approved its use as a color additive.
"Lead acetate has been used in the United States and throughout the
world as a color additive for gradual acting dyes to color gray hair for
more than 40 years," Robinson said. "These dyes have been extensively
tested for safety by re nowned scientists."
Robert Cohen may be reached at rcohen at starledger.com or (202) 383-7823.
⌐ 2007 The Star Ledger
⌐ 2007 NJ.com All Rights Reserved.
Deborah L. DeBiasi
Email: dldebiasi at deq.virginia.gov
WEB site address: www.deq.virginia.gov
Virginia Department of Environmental Quality
Office of Water Permit Programs
Industrial Pretreatment/Toxics Management Program
Mail: P.O. Box 1105, Richmond, VA 23218 (NEW!)
Location: 629 E. Main Street, Richmond, VA 23219
PH: 804-698-4028
FAX: 804-698-4032
------------------------------
Message: 2
Date: Wed, 30 May 2007 16:57:03 -0400
From: "DeBiasi,Deborah" <dldebiasi at deq.virginia.gov>
Subject: [Pharmwaste] PPCP webcast presentations from May 22, 07 in
Sacramento CA
To: <pharmwaste at lists.dep.state.fl.us>
Message-ID:
<6C097DA58429B743A67070F98BE73A370120650E at deqex01.deq.local>
Content-Type: text/plain; charset="us-ascii"
If you missed the webcast conference last week, the presentations can
be
accessed from the agenda below:
http://www.dtsc.ca.gov/AssessingRisk/PPCP/upload/Agenda1.pdf
Pharmaceuticals and Personal Care Products
in the Environment Symposium
May 22, 2007
10:00 AM - 3:30 PM
Cal/EPA 1001 I Street
Byron Sher Auditorium, 2nd Floor
Sacramento, California
Deborah L. DeBiasi
Email: dldebiasi at deq.virginia.gov
WEB site address: www.deq.virginia.gov
Virginia Department of Environmental Quality
Office of Water Permit Programs
Industrial Pretreatment/Toxics Management Program
Mail: P.O. Box 1105, Richmond, VA 23218 (NEW!)
Location: 629 E. Main Street, Richmond, VA 23219
PH: 804-698-4028
FAX: 804-698-4032
------------------------------
Message: 3
Date: Thu, 31 May 2007 15:15:55 -0500
From: Catherine Zimmer <zimme053 at umn.edu>
Subject: Re: [Pharmwaste] Role of the Pharmacist in PharmWaste
Management
To: drmille at blue.weeg.uiowa.edu
Cc: pharmwaste at lists.dep.state.fl.us
Message-ID: <465F2CFB.8070207 at umn.edu>
Content-Type: text/plain; charset=ISO-8859-1; format=flowed
Hi Daniel,
Pharmaceutical waste can and should be reduced at the source. See the
fact sheet we developed regarding our work with two MN hospitals on
pharmaceutical waste reduction:
www.mntap.umn.edu/health/94-PharmWaste.htm
Catherine Zimmer
Health Care Specialist
Minnesota Technical Assistance Program
University of Minnesota
612/624-4635, 800/247-0015
http://www.mntap.umn.edu
Helping Minnesota businesses maximize resource efficiency, prevent
pollution and reduce costs.
drmille at blue.weeg.uiowa.edu wrote:
> Hello Everyone,
>
> My name is Daniel Miller, a 4th year pharmacy student at the
> University of Iowa?s College of Pharmacy. I am currently working on
a
> project for Health Care Without Harm and Hospitals for a Healthy
> Environment to create a scoping document on pharmacists? role(s) in
> pharmaceutical waste management. I know this list-serve is monitored
> by a large variety of professionals and I want to take advantage of
> that fact.
>
> I am putting out an information request to the list-serve for the
> following items:
>
> 1) How do you feel pharmacists are currently impacting pharmaceutical
> waste management in your respective communities/hospitals/health care
> system/etc.?
> 2) How could pharmacists improve their roles in pharmaceutical waste
> management?
> 3) What barriers do you perceive that prevent pharmacists from
> efficiently assisting pharmaceutical waste management? (mainly
> hospital regs, state regs, apathy, lack of education, etc.)
>
>
> In your responses, please let me know what your position is and where
> you are from. As well, if you have any interesting regulations,
> hindrances, or circumstances specific to your hospital or health care
> facility, let me know. Any help would be much appreciated and credit
> will definitely be given where it is due.
>
> Thank you in advance for your responses.
>
>
> Sincerely Grateful,
>
> Daniel Miller
>
> --Daniel R Miller
> Student Pharmacist
> 737 Michael St #45
> Iowa City, IA 52246
> 319-541-7638
>
>
>
>
>
> _______________________________________________
> Pharmwaste mailing list
> Pharmwaste at lists.dep.state.fl.us
> http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste
------------------------------
Message: 4
Date: Thu, 31 May 2007 17:28:29 -0400
From: "gressitt" <gressitt at uninets.net>
Subject: [Pharmwaste] Cocaine in the air in Italy: study
To: <pharmwaste at lists.dep.state.fl.us>,
<naddg at www.mainecenteronaging.org>,
<unused at www.mainecenteronaging.org>,
<drugdisposal at mainebenzo.org>,
<drugpolicy at www.mainecenteronaging.org>,
<steermbsg at www.mainecenteronaging.org>
Message-ID: <010501c7a3ca$a2bf0f20$e83d2d60$@net>
Content-Type: text/plain; charset="us-ascii"
>From the Po river study to Rome...hmm, I think another study must be
pending
here in the US...Would air have fewer contaminants or issues such as
bacterial that water studies might have? Ah, the air folks now get
drawn
into this beyond just the incineration question.
Stevan Gressitt, M.D.
207-441-0291
www.mainebenzo.org
http://www.breitbart.com/article.php?id=070531194944.k2o7lrkl&show_article=1
&catnum=-1
------------------------------
Message: 5
Date: Thu, 31 May 2007 16:40:45 -0500
From: drmille at blue.weeg.uiowa.edu
Subject: [Pharmwaste] Call Out for Karen Norris
To: pharmwaste at lists.dep.state.fl.us
Message-ID: <20070531164045.1fbje7fpq8g8wsg4 at webmail.uiowa.edu>
Content-Type: text/plain; charset=ISO-8859-1; DelSp="Yes";
format="flowed"
To Karen Norris,
Please contact me back. I was told by Stevan Gressitt to blip this
list-serve and find you to set up a good time to have a thorough
discussion regarding pharmaceutical waste management. We can discuss
specific topics further once we get our conversation off this
list-serve.
Thanks!
-Daniel Miller
--
Daniel R Miller
Student Pharmacist
737 Michael St #45
Iowa City, IA 52246
319-541-7638
------------------------------
Message: 6
Date: Thu, 31 May 2007 18:46:09 -0400
From: "gressitt" <gressitt at uninets.net>
Subject: RE: [Pharmwaste] Call Out for Karen Norris
To: <drmille at blue.weeg.uiowa.edu>, <pharmwaste at lists.dep.state.fl.us>
Message-ID: <013e01c7a3d5$7bf7fe00$73e7fa00$@net>
Content-Type: text/plain; charset="us-ascii"
Dr. Miller wishes to contact Karin North in California, and I do not
have
her contact information with me. Stevan Gressitt
-----Original Message-----
From: pharmwaste-bounces at lists.dep.state.fl.us
[mailto:pharmwaste-bounces at lists.dep.state.fl.us] On Behalf Of
drmille at blue.weeg.uiowa.edu
Sent: Thursday, May 31, 2007 5:41 PM
To: pharmwaste at lists.dep.state.fl.us
Subject: [Pharmwaste] Call Out for Karen Norris
To Karen Norris,
Please contact me back. I was told by Stevan Gressitt to blip this
list-serve and find you to set up a good time to have a thorough
discussion regarding pharmaceutical waste management. We can discuss
specific topics further once we get our conversation off this
list-serve.
Thanks!
-Daniel Miller
--
Daniel R Miller
Student Pharmacist
737 Michael St #45
Iowa City, IA 52246
319-541-7638
_______________________________________________
Pharmwaste mailing list
Pharmwaste at lists.dep.state.fl.us
http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste
------------------------------
Message: 7
Date: Fri, 1 Jun 2007 09:14:42 -0700
From: "Jackson, Jennifer" <jacksonj at ebmud.com>
Subject: [Pharmwaste] CA Pharmaceutical Take-back Legislation Passes
Senate!
To: <BAPPG at yahoogroups.com>, <SFBAY_Pharm_Disp at yahoogroups.com>,
<pharmwaste at lists.dep.state.fl.us>
Message-ID: <D64A54BFA87D3C459F37539F6D354C08266637 at exch1.win.ebmud>
Content-Type: text/plain; charset="iso-8859-1"
FYI --
CA State Senator Joe Simitian's SB 966 passed the Senate Floor with the
bare minimum 21 vote Thursday morning.áNow it moves to the CA Assembly,
likely to several committees first.
http://www.leginfo.ca.gov/cgi-bin/postquery?bill_number=sb_966&sess=CUR&house=B&author=simitian
Letters of support are needed! They can be mailed and faxed to:
916-322-3519
The Honorable Joe Simitian
Chair, Senate Environmental Quality Committee
California State Capitol
Sacramento, CA 95814
------------------------------
_______________________________________________
Pharmwaste mailing list
Pharmwaste at lists.dep.state.fl.us
http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste
End of Pharmwaste Digest, Vol 20, Issue 1
*****************************************
More information about the Pharmwaste
mailing list